Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

TOKYO – The AI basic plan rough draft, which the government eyes to formulate by the end of the year, includes promotion of AI use in public institutions, it has been learned.